Clinical trialNCT02377531UnknownInterventional

Early Screen and Treatment for Gestational Diabetes

SponsorUniversity of South FloridaEnrollment1,020Gestational Diabetes

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

In the current study we aim to determine if early glucose screening and treatment among women at high risk for GDM improves perinatal outcome and decreases gestational weight gain. Half of the participant will be assigned to an early glucose screen group (12-18 weeks) and treatment if necessary and the other half to a standard 24-28 weeks glucose screen.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Alejandro Rodriguez, MD
University of South Florida
Principal Investigator
clinicaltrials.gov ↗
Judette Louis, MD, MPH
University of South Florida
Study Chair
clinicaltrials.gov ↗
Linda Odibo
University of South Florida
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Tgh Health Park Genesis Clinic
Tampa, Florida, United States
Usf Health South Tampa Center for Advanced Healthcare
Tampa, Florida, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Mar 2015
Primary completion: 31 Jul 2021
Completion: 30 Sept 2021
Last update posted: 2 Jun 2021
Registered enrollment: 1,020
Registry id: NCT02377531

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.